You are here

  • Home
  • Archive
  • Volume 29, Issue 4
  • Report from the Faculty of Family Planning and Reproductive Health Care AGM, May 2003: Medical termination of pregnancy in the late first trimester

Article Text

Article menu

Download PDFPDF

Conference Report
Report from the Faculty of Family Planning and Reproductive Health Care AGM, May 2003: Medical termination of pregnancy in the late first trimester
  1. P Stewart, FRCOG, Consultant Obstetrician and Gynaecologist1,
  2. J Fletcher, RN, MA, Clinical Nurse Specialist1 and
  3. A Sharma, MRCOG, Consultant in Family Planning and Reproductive Health Care2
  1. Royal Hallamshire Hospital, Sheffield, UK
  2. Central Health Clinic, Sheffield, UK
  1. Correspondence Mr P Stewart, Department of Obstetrics and Gynaecology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. E-mail: rpeter.stewart{at}sth.nhs.uk

Abstract

In the UK, mifepristone and gemeprost are licensed for medical termination of pregnancy (TOP) in the first trimester up to 63 days' amenorrhoea. Current practice, however, is to use low-dose (200 mg) mifepristone and misoprostol. We report a large cohort study using these drugs for medical TOP in the first trimester after 63 days amenorrhoea. Of 415 patients undergoing the procedure, 392 (95%) aborted completely and 96% required only two doses of misoprostol. We conclude that the regime is effective with few complications, however certain safeguards may be necessary for its widespread introduction

https://doi.org/10.1783/147118903101197908

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.